According to this point, the already known “Obesity Paradox” has been assessed in obese
chronic kidney disease (CKD) patients [2, 3]. Indeed, Fleischmann et al.[2] showed higher …

Obesity is a multifaceted problem and has the potential to cause or contribute to metabolic
disorders such as diabetes, dyslipidemia, hypertension, and the metabolic syndrome …

Background: Obesity is a risk factor for cardiovascular disease and death in people without
chronic kidney disease (CKD), but the effect of obesity in people with CKD is uncertain …

In addition to its role as a risk factor for de novo CKD, there appears to be a consistent
association between obesity and lower mortality in those with established CKD, particularly …

Introduction: Mounting evidence in the literature describes a reverse association, whereby
obesity may have a protective effect on mortality–the “obesity paradox.” Due to the …

Obesity, a risk factor for de novo chronic kidney disease (CKD), confers survival advantages
in advanced CKD. This so-called obesity paradox is the archetype of the reverse …

Background Obesity is a risk factor for de novo chronic kidney disease (CKD) in the general
population. Obesity has been increasingly prevalent in patients with CKD and may lead to …

There is a pandemic of obesity worldwide and in Europe up to 30% of the adult population is
already obese. Obesity is strongly related to the risk of CKD, progression of CKD, and end …

Overweight (body mass index [BMI]= 25-30 kg/m2) and obesity (BMI> 30 kg/m2) have
become mass phenomena with a pronounced upward trend in prevalence in most countries …

F or many years, the adverse effect of obesity on kidney outcomes has been recognized in
patients with primary kidney diseases in general 1 as well as in patients with specific …